BS23 Gender and aspirin impact generation of procoagulant oxidized phospholipids by platelets in a healthy human cohort. (May 2019)
- Record Type:
- Journal Article
- Title:
- BS23 Gender and aspirin impact generation of procoagulant oxidized phospholipids by platelets in a healthy human cohort. (May 2019)
- Main Title:
- BS23 Gender and aspirin impact generation of procoagulant oxidized phospholipids by platelets in a healthy human cohort
- Authors:
- Protty, Majd
Brasher, Christopher
Tyrrell, Victoria
Rodrigues, Patricia
Aldrovandi, Maceler
Obaji, Samya
Jenkins, P Vince
Collins, Peter
O'Donnell, Valerie - Abstract:
- Abstract : Background: Phospholipids on the surface of platelets play a key role in supporting coagulation in both health and disease. Alterations to phospholipid composition in platelets can contribute to thrombotic and bleeding disorders. We recently identified pro-coagulant enzymatically oxidized phospholipids (eoxPL) generated by platelets in response to thrombin activation via cyclooxygenase-1 (COX) and 12-lipoxygenase (LOX). It is not known how these lipids vary in relation to aspirin (a COX inhibitor) supplementation and/or gender. Methods: Twenty-eight healthy volunteers (14 males, 14 females) donated blood for platelet isolation at baseline (following a 14-day NSAID washout) and after 7-day supplementation with 75 mg aspirin. Repeat sampling took place 2 months and 4 months later to account for variations over time. Lipids were extracted from platelets either basally or following 30 min thrombin activation then analysed using liquid chromatography with tandem mass-spectrometry (LC-MS/MS) for the 49 most abundant eoxPL molecular species. Results: The majority (96%) of eoxPL increased in response to thrombin activation of platelets. Gender differences were observed with a trend towards higher levels generated by females. Correlation analysis highlighted clustering of eoxPL by enzymatic origin (12-LOX versus COX-1). Aspirin supplementation decreased eoxPL generated via COX-1 in both genders, but in males it increased levels of those generated by 12-LOX (p<0.05).Abstract : Background: Phospholipids on the surface of platelets play a key role in supporting coagulation in both health and disease. Alterations to phospholipid composition in platelets can contribute to thrombotic and bleeding disorders. We recently identified pro-coagulant enzymatically oxidized phospholipids (eoxPL) generated by platelets in response to thrombin activation via cyclooxygenase-1 (COX) and 12-lipoxygenase (LOX). It is not known how these lipids vary in relation to aspirin (a COX inhibitor) supplementation and/or gender. Methods: Twenty-eight healthy volunteers (14 males, 14 females) donated blood for platelet isolation at baseline (following a 14-day NSAID washout) and after 7-day supplementation with 75 mg aspirin. Repeat sampling took place 2 months and 4 months later to account for variations over time. Lipids were extracted from platelets either basally or following 30 min thrombin activation then analysed using liquid chromatography with tandem mass-spectrometry (LC-MS/MS) for the 49 most abundant eoxPL molecular species. Results: The majority (96%) of eoxPL increased in response to thrombin activation of platelets. Gender differences were observed with a trend towards higher levels generated by females. Correlation analysis highlighted clustering of eoxPL by enzymatic origin (12-LOX versus COX-1). Aspirin supplementation decreased eoxPL generated via COX-1 in both genders, but in males it increased levels of those generated by 12-LOX (p<0.05). Importantly, elevated levels of 12-hydroxyeicosatetraenoic acid (12-HETE)-containing eoxPL, which are known to be procoagulant, were observed. In contrast, generation of free 12-HETE was not affected by aspirin. Conclusion: In this study, we found an influence of both gender and aspirin supplementation on the generation of eoxPL in thrombin-activated platelets from healthy volunteers. Further characterisation of the gender influence may reveal novel mechanisms that contribute to the risk of arterial thrombosis in human populations. Conflict of interest: None declared … (more)
- Is Part Of:
- Heart. Volume 105(2019)Supplement 6
- Journal:
- Heart
- Issue:
- Volume 105(2019)Supplement 6
- Issue Display:
- Volume 105, Issue 6 (2019)
- Year:
- 2019
- Volume:
- 105
- Issue:
- 6
- Issue Sort Value:
- 2019-0105-0006-0000
- Page Start:
- A156
- Page End:
- A156
- Publication Date:
- 2019-05
- Subjects:
- lipidomics -- platelet -- thrombosis
Heart -- Diseases -- Treatment -- Periodicals
Cardiology -- Periodicals
616.12 - Journal URLs:
- http://www.bmj.com/archive ↗
http://heart.bmj.com ↗
http://www.heartjnl.com ↗ - DOI:
- 10.1136/heartjnl-2019-BCS.186 ↗
- Languages:
- English
- ISSNs:
- 1355-6037
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 19674.xml